Immediate Impact
2 by Nobel laureates 1 from Science/Nature 61 standout
Citing Papers
Analysis of Breast Cancer Mortality in the US—1975 to 2019
2024 Standout
Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer (TROPiCS-02): a randomised, open-label, multicentre, phase 3 trial
2023 Standout
Works of N. D'Acosta being referenced
Phase II Study of Eribulin Mesylate, a Halichondrin B Analog, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane
2009
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| N. D'Acosta | 297 | 290 | 46 | 100 | 20 | 613 | |
| Jackie C. Bloomer | 178 | 264 | 31 | 258 | 20 | 739 | |
| Jean‐Paul Leroux | 127 | 326 | 17 | 203 | 23 | 681 | |
| K. N. Ham | 86 | 203 | 49 | 91 | 21 | 563 | |
| Amarjit S. Chaudhry | 204 | 306 | 28 | 179 | 20 | 720 | |
| Leslie R. Schwarz | 374 | 147 | 14 | 149 | 21 | 635 | |
| Sidney D. Nelson | 192 | 425 | 14 | 174 | 9 | 655 | |
| G J Mulder | 226 | 207 | 29 | 249 | 29 | 719 | |
| Chao-Hen Kuo | 124 | 260 | 20 | 147 | 27 | 592 | |
| Henk Koster | 172 | 283 | 10 | 156 | 22 | 689 | |
| G. Seidel | 101 | 280 | 44 | 161 | 40 | 561 |
All Works
Loading papers...